Barbel Rohrer

Title: Barbel Rohrer: Innovator in Age-Related Macular Degeneration Treatment

Introduction

Barbel Rohrer is a notable inventor based in Charleston, SC (US). He has made significant contributions to the field of medicine, particularly in the treatment of age-related macular degeneration (AMD). His innovative approach focuses on utilizing anti-C5a antibodies to combat this prevalent condition.

Latest Patents

Barbel Rohrer holds a patent for "Methods of treating age-related macular degeneration in a patient comprising administering an anti-C5a antibody." This patent outlines a method that involves administering an effective amount of a C5 inhibitor or a C5a inhibitor to treat AMD in patients. This breakthrough has the potential to improve the quality of life for many individuals suffering from this debilitating condition. He has 1 patent to his name.

Career Highlights

Rohrer is currently associated with Alexion Pharmaceuticals, Inc., a leading biopharmaceutical company known for its innovative therapies. His work at Alexion has allowed him to focus on developing treatments that address critical medical needs, particularly in the realm of rare diseases and conditions.

Collaborations

One of his notable collaborators is Yi Wang, who is also a key figure in the research and development of treatments for AMD. Their combined expertise contributes to the advancement of medical science and the development of effective therapies.

Conclusion

Barbel Rohrer is a pioneering inventor whose work in treating age-related macular degeneration showcases the importance of innovation in medicine. His contributions have the potential to make a significant impact on patient care and treatment options.